PDB Short entry for 1LW0
HEADER    TRANSFERASE                             30-MAY-02   1LW0              
TITLE     CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE                       
TITLE    2 TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE                             
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE;                               
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: P66;                                                       
COMPND   5 SYNONYM: HIV-1 RT;                                                   
COMPND   6 EC: 2.7.7.49;                                                        
COMPND   7 ENGINEERED: YES;                                                     
COMPND   8 MUTATION: YES;                                                       
COMPND   9 MOL_ID: 2;                                                           
COMPND  10 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE;                               
COMPND  11 CHAIN: B;                                                            
COMPND  12 FRAGMENT: P51;                                                       
COMPND  13 SYNONYM: HIV-1 RT;                                                   
COMPND  14 EC: 2.7.7.49;                                                        
COMPND  15 ENGINEERED: YES;                                                     
COMPND  16 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 
SOURCE   3 ORGANISM_TAXID: 11676;                                               
SOURCE   4 GENE: HIV-1 POL;                                                     
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: TG-1;                                      
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PKK233-2;                                 
SOURCE  10 MOL_ID: 2;                                                           
SOURCE  11 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 
SOURCE  12 ORGANISM_TAXID: 11676;                                               
SOURCE  13 GENE: HIV-1 POL;                                                     
SOURCE  14 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE  15 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE  16 EXPRESSION_SYSTEM_STRAIN: TG-1;                                      
SOURCE  17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  18 EXPRESSION_SYSTEM_PLASMID: PKK233-2                                  
KEYWDS    HIV-1 REVERSE TRANSCRIPTASE, AIDS, AZT, 3TC, NRTI,                    
KEYWDS   2 NEVIRAPINE, DRUG RESISTANCE MUTATIONS, TRANSFERASE                   
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    J.REN,P.P.CHAMBERLAIN,C.E.NICHOLS,L.DOUGLAS,D.I.STUART,               
AUTHOR   2 D.K.STAMMERS                                                         
REVDAT   2   24-FEB-09 1LW0    1       VERSN                                    
REVDAT   1   30-OCT-02 1LW0    0                                                
JRNL        AUTH   P.P.CHAMBERLAIN,J.REN,C.E.NICHOLS,L.DOUGLAS,                 
JRNL        AUTH 2 J.LENNERSTRAND,B.A.LARDER,D.I.STUART,D.K.STAMMERS            
JRNL        TITL   CRYSTAL STRUCTURES OF ZIDOVUDINE- OR                         
JRNL        TITL 2 LAMIVUDINE-RESISTANT HUMAN IMMUNODEFICIENCY VIRUS            
JRNL        TITL 3 TYPE 1 REVERSE TRANSCRIPTASES CONTAINING MUTATIONS           
JRNL        TITL 4 AT CODONS 41, 184, AND 215.                                  
JRNL        REF    J.VIROL.                      V.  76 10015 2002              
JRNL        REFN                   ISSN 0022-538X                               
JRNL        PMID   12208978                                                     
JRNL        DOI    10.1128/JVI.76.19.10015-10019.2002                           
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   J.REN,C.E.NICHOLS,L.E.BIRD,P.CHAMBERLAIN,                    
REMARK   1  AUTH 2 K.L.WEAVER,S.A.SHORT,D.I.STUART,D.K.STAMMERS                 
REMARK   1  TITL   STRUCTURAL MECHANISMS OF DRUG RESISTANCE FOR                 
REMARK   1  TITL 2 MUTATIONS AT CODONS 181 AND 188 IN HIV-1 REVERSE             
REMARK   1  TITL 3 TRANSCRIPTASE AND THE IMPROVED RESILIENCE OF                 
REMARK   1  TITL 4 SECOND GENERATION NON-NUCLEOSIDE INHIBITORS                  
REMARK   1  REF    J.MOL.BIOL.                   V. 312   795 2001              
REMARK   1  REFN                   ISSN 0022-2836                               
REMARK   1  DOI    10.1006/JMBI.2001.4988                                       
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   J.H.CHAN,J.S.HONG,R.N.HUNTER III,G.F.ORR,J.R.COWAN,          
REMARK   1  AUTH 2 D.B.SHERMAN,S.M.SPARKS,B.E.REITTER,C.W.ANDREWS III,          
REMARK   1  AUTH 3 R.J.HAZEN,M.ST CLAIR,L.R.BOONE,R.G.FERRIS,                   
REMARK   1  AUTH 4 K.L.CREECH,G.B.ROBERTS,S.A.SHORT,K.L.WEAVER,                 
REMARK   1  AUTH 5 R.J.OTT,J.REN,A.L.HOPKINS,D.I.STUART,D.K.STAMMERS            
REMARK   1  TITL   2-AMINO-6-ARYLSULFONYLBENZONITRILES AS                       
REMARK   1  TITL 2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF           
REMARK   1  TITL 3 HIV-1                                                        
REMARK   1  REF    J.MED.CHEM.                   V.  44  1866 2001              
REMARK   1  REFN                   ISSN 0022-2623                               
REMARK   1  DOI    10.1021/JM0004906                                            
REMARK   1 REFERENCE 3                                                          
REMARK   1  AUTH   J.REN,J.MILTON,K.L.WEAVER,S.A.SHORT,D.I.STUART,              
REMARK   1  AUTH 2 D.K.STAMMERS                                                 
REMARK   1  TITL   STRUCTURAL BASIS FOR THE RESILIENCE OF EFAVIRENZ             
REMARK   1  TITL 2 (DMP-266) TO DRUG RESISTANCE MUTATIONS IN HIV-1              
REMARK   1  TITL 3 REVERSE TRANSCRIPTASE                                        
REMARK   1  REF    STRUCTURE                     V.   8  1089 2000              
REMARK   1  REFN                   ISSN 0969-2126                               
REMARK   1  DOI    10.1016/S0969-2126(00)00513-X                                
REMARK   1 REFERENCE 4                                                          
REMARK   1  AUTH   J.REN,C.E.NICHOLS,L.E.BIRD,T.FUJIWARA,H.SUGIMOTO,            
REMARK   1  AUTH 2 D.I.STUART,D.K.STAMMERS                                      
REMARK   1  TITL   BINDING OF THE SECOND GENERATION NON-NUCLEOSIDE              
REMARK   1  TITL 2 INHIBITOR S-1153 TO HIV-1 REVERSE TRANSCRIPTASE              
REMARK   1  TITL 3 INVOLVES EXTENSIVE MAIN CHAIN HYDROGEN BONDING               
REMARK   1  REF    J.BIOL.CHEM.                  V. 275 14316 2000              
REMARK   1  REFN                   ISSN 0021-9258                               
REMARK   1  DOI    10.1074/JBC.275.19.14316                                     
REMARK   1 REFERENCE 5                                                          
REMARK   1  AUTH   J.REN,J.DIPROSE,J.WARREN,R.M.ESNOUF,L.E.BIRD,                
REMARK   1  AUTH 2 S.IKEMIZU,M.SLATER,J.MILTON,J.BALZARINI,D.I.STUART,          
REMARK   1  AUTH 3 D.K.STAMMERS                                                 
REMARK   1  TITL   PHENETHYLTHIAZOLYLTHIOUREA (PETT) NON-NUCLEOSIDE             
REMARK   1  TITL 2 INHIBITORS OF HIV-1 AND HIV-2 REVERSE                        
REMARK   1  TITL 3 TRANSCRIPTASES. STRUCTURAL AND BIOCHEMICAL ANALYSES          
REMARK   1  REF    J.BIOL.CHEM.                  V. 275  5633 2000              
REMARK   1  REFN                   ISSN 0021-9258                               
REMARK   1  DOI    10.1074/JBC.275.8.5633                                       
REMARK   1 REFERENCE 6                                                          
REMARK   1  AUTH   J.REN,R.M.ESNOUF,A.L.HOPKINS,D.I.STUART,                     
REMARK   1  AUTH 2 D.K.STAMMERS                                                 
REMARK   1  TITL   CRYSTALLOGRAPHIC ANALYSIS OF THE BINDING MODES OF            
REMARK   1  TITL 2 THIAZOLOISOINDOLINONE NON-NUCLEOSIDE INHIBITORS TO           
REMARK   1  TITL 3 HIV-1 REVERSE TRANSCRIPTASE AND COMPARISON WITH              
REMARK   1  TITL 4 MODELING STUDIES                                             
REMARK   1  REF    J.MED.CHEM.                   V.  42  3845 1999              
REMARK   1  REFN                   ISSN 0022-2623                               
REMARK   1  DOI    10.1021/JM990275T                                            
REMARK   1 REFERENCE 7                                                          
REMARK   1  AUTH   A.L.HOPKINS,J.REN,H.TANAKA,M.BABA,M.OKAMATO,                 
REMARK   1  AUTH 2 D.I.STUART,D.K.STAMMERS                                      
REMARK   1  TITL   DESIGN OF MKC-442 (EMIVIRINE) ANALOGUES WITH                 
REMARK   1  TITL 2 IMPROVED ACTIVITY AGAINST DRUG-RESISTANT HIV                 
REMARK   1  TITL 3 MUTANTS                                                      
REMARK   1  REF    J.MED.CHEM.                   V.  42  4500 1999              
REMARK   1  REFN                   ISSN 0022-2623                               
REMARK   1  DOI    10.1021/JM990192C                                            
REMARK   1 REFERENCE 8                                                          
REMARK   1  AUTH   J.REN,R.M.ESNOUF,A.L.HOPKINS,J.WARREN,J.BALZARINI,           
REMARK   1  AUTH 2 D.I.STUART,D.K.STAMMERS                                      
REMARK   1  TITL   CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE            
REMARK   1  TITL 2 IN COMPLEX WITH CARBOXANILIDE DERIVATIVES                    
REMARK   1  REF    BIOCHEMISTRY                  V.  37 14394 1998              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   1  DOI    10.1021/BI981309M                                            
REMARK   1 REFERENCE 9                                                          
REMARK   1  AUTH   J.REN,R.M.ESNOUF,A.L.HOPKINS,E.Y.JONES,I.KIRBY,              
REMARK   1  AUTH 2 J.KEELING,C.K.ROSS,B.A.LARDER,D.I.STUART,                    
REMARK   1  AUTH 3 D.K.STAMMERS                                                 
REMARK   1  TITL   3'-AZIDO-3'-DEOXYTHYMIDINE DRUG RESISTANCE                   
REMARK   1  TITL 2 MUTATIONS IN HIV-1 REVERSE TRANSCRIPTASE CAN                 
REMARK   1  TITL 3 INDUCE LONG RANGE CONFORMATIONAL CHANGES                     
REMARK   1  REF    PROC.NATL.ACAD.SCI.USA        V.  95  9518 1998              
REMARK   1  REFN                   ISSN 0027-8424                               
REMARK   1  DOI    10.1073/PNAS.95.16.9518                                      
REMARK   1 REFERENCE 10                                                         
REMARK   1  AUTH   R.M.ESNOUF,J.REN,E.F.GARMAN,D.O.SOMERS,C.K.ROSS,             
REMARK   1  AUTH 2 E.Y.JONES,D.K.STAMMERS,D.I.STUART                            
REMARK   1  TITL   CONTINUOUS AND DISCONTINUOUS CHANGES IN THE UNIT             
REMARK   1  TITL 2 CELL OF HIV-1 REVERSE TRANSCRIPTASE CRYSTALS ON              
REMARK   1  TITL 3 DEHYDRATION                                                  
REMARK   1  REF    ACTA CRYSTALLOGR.,SECT.D      V.  54   938 1998              
REMARK   1  REFN                   ISSN 0907-4449                               
REMARK   1  DOI    10.1107/S0907444998004284                                    
REMARK   1 REFERENCE 11                                                         
REMARK   1  AUTH   R.M.ESNOUF,J.REN,A.L.HOPKINS,C.K.ROSS,E.Y.JONES,             
REMARK   1  AUTH 2 D.K.STAMMERS,D.I.STUART                                      
REMARK   1  TITL   UNIQUE FEATURES IN THE STRUCTURE OF THE COMPLEX              
REMARK   1  TITL 2 BETWEEN HIV-1 REVERSE TRANSCRIPTASE AND THE                  
REMARK   1  TITL 3 BIS(HETEROARYL)PIPERAZINE (BHAP) U-90152 EXPLAIN             
REMARK   1  TITL 4 RESISTANCE MUTATIONS FOR THIS NON-NUCLEOSIDE                 
REMARK   1  TITL 5 INHIBITOR                                                    
REMARK   1  REF    PROC.NATL.ACAD.SCI.USA        V.  94  3984 1997              
REMARK   1  REFN                   ISSN 0027-8424                               
REMARK   1  DOI    10.1073/PNAS.94.8.3984                                       
REMARK   1 REFERENCE 12                                                         
REMARK   1  AUTH   A.L.HOPKINS,J.REN,R.M.ESNOUF,B.E.WILLCOX,E.Y.JONES,          
REMARK   1  AUTH 2 C.K.ROSS,T.MIYASAKA,R.T.WALKER,H.TANAKA,                     
REMARK   1  AUTH 3 D.K.STAMMERS,D.I.STUART                                      
REMARK   1  TITL   COMPLEXES OF HIV-1 REVERSE TRANSCRIPTASE WITH                
REMARK   1  TITL 2 INHIBITORS OF THE HEPT SERIES REVEAL                         
REMARK   1  TITL 3 CONFORMATIONAL CHANGES RELEVANT TO THE DESIGN OF             
REMARK   1  TITL 4 POTENT NON-NUCLEOSIDE INHIBITORS                             
REMARK   1  REF    J.MED.CHEM.                   V.  39  1589 1996              
REMARK   1  REFN                   ISSN 0022-2623                               
REMARK   1  DOI    10.1021/JM960056X                                            
REMARK   1 REFERENCE 13                                                         
REMARK   1  AUTH   J.REN,R.M.ESNOUF,A.L.HOPKINS,C.K.ROSS,E.Y.JONES,             
REMARK   1  AUTH 2 D.K.STAMMERS,D.I.STUART                                      
REMARK   1  TITL   THE STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE                 
REMARK   1  TITL 2 COMPLEXED WITH 9-CHLORO-TIBO: LESSONS FOR                    
REMARK   1  TITL 3 INHIBITOR DESIGN                                             
REMARK   1  REF    STRUCTURE                     V.   3   915 1995              
REMARK   1  REFN                   ISSN 0969-2126                               
REMARK   1 REFERENCE 14                                                         
REMARK   1  AUTH   J.REN,R.M.ESNOUF,E.GARMAN,D.O.SOMERS,C.K.ROSS,               
REMARK   1  AUTH 2 I.KIRBY,J.KEELING,G.DARBY,E.Y.JONES,D.I.STUART,              
REMARK   1  AUTH 3 D.K.STAMMERS                                                 
REMARK   1  TITL   HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR             
REMARK   1  TITL 2 RT-INHIBITOR COMPLEXES                                       
REMARK   1  REF    NAT.STRUCT.BIOL.              V.   2   293 1995              
REMARK   1  REFN                   ISSN 1072-8368                               
REMARK   1 REFERENCE 15                                                         
REMARK   1  AUTH   R.M.ESNOUF,J.REN,C.K.ROSS,E.Y.JONES,D.K.STAMMERS,            
REMARK   1  AUTH 2 D.I.STUART                                                   
REMARK   1  TITL   MECHANISM OF INHIBITION OF HIV-1 REVERSE                     
REMARK   1  TITL 2 TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS                   
REMARK   1  REF    NAT.STRUCT.BIOL.              V.   2   303 1995              
REMARK   1  REFN                   ISSN 1072-8368                               
REMARK   1 REFERENCE 16                                                         
REMARK   1  AUTH   D.K.STAMMERS,D.O.SOMERS,C.K.ROSS,I.KIRBY,P.H.RAY,            
REMARK   1  AUTH 2 J.E.WILSON,M.NORMAN,J.REN,R.M.ESNOUF,E.GARMAN,               
REMARK   1  AUTH 3 E.Y.JONES,D.I.STUART                                         
REMARK   1  TITL   CRYSTALS OF HIV-1 REVERSE TRANSCRIPTASE                      
REMARK   1  TITL 2 DIFFRACTING TO 2.2 A RESOLUTION                              
REMARK   1  REF    J.MOL.BIOL.                   V. 242   586 1994              
REMARK   1  REFN                   ISSN 0022-2836                               
REMARK   1  DOI    10.1006/JMBI.1994.1604                                       
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.80 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.0                                              
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,             
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : ENGH & HUBER                                    
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 29.85                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 1863893.730                    
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000                         
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 93.8                           
REMARK   3   NUMBER OF REFLECTIONS             : 25107                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.219                           
REMARK   3   FREE R VALUE                     : 0.301                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.000                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 1257                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.009                           
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 10                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.80                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.90                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 87.20                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 2167                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.3440                       
REMARK   3   BIN FREE R VALUE                    : 0.4090                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 5.00                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 114                          
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.038                        
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 7516                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 30                                      
REMARK   3   SOLVENT ATOMS            : 0                                       
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 68.90                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 83.30                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : -7.15000                                             
REMARK   3    B22 (A**2) : -4.77000                                             
REMARK   3    B33 (A**2) : 11.92000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            
REMARK   3   ESD FROM SIGMAA              (A) : NULL                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.53                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.56                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.012                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.70                            
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 24.20                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 1.13                            
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 4.970 ; 4.000                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 8.230 ; 8.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 8.320 ; 6.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 12.680; 12.000               
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : FLAT MODEL                                           
REMARK   3   KSOL        : 0.30                                                 
REMARK   3   BSOL        : 34.16                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM                              
REMARK   3  PARAMETER FILE  2  : WATER_REP.PARAM                                
REMARK   3  PARAMETER FILE  3  : ION.PARAM                                      
REMARK   3  PARAMETER FILE  4  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP                                    
REMARK   3  TOPOLOGY FILE  2   : WATER_REP.TOP                                  
REMARK   3  TOPOLOGY FILE  3   : ION.TOP                                        
REMARK   3  TOPOLOGY FILE  4   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1LW0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-JUN-02.                  
REMARK 100 THE RCSB ID CODE IS RCSB016330.                                      
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 27-JUN-98                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 5.00                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ESRF                               
REMARK 200  BEAMLINE                       : ID2                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9903                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MAR SCANNER 345 MM PLATE           
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 25400                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.800                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 30.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : -1.500                             
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 93.2                               
REMARK 200  DATA REDUNDANCY                : 3.600                              
REMARK 200  R MERGE                    (I) : 0.06100                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 13.8000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.90                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 78.5                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 1.600                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: X-PLOR                                                
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 45.76                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.00, VAPOR DIFFUSION, SITTING        
REMARK 280  DROP, TEMPERATURE 277K                                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       69.85000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       32.80000            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       57.50000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       32.80000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       69.85000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       57.50000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 300 REMARK: HIV-1 RT IS A HETERODIMER CONSISTING OF A P66 AND A P51      
REMARK 300 SUBUNITS, THE P51 CONTAINS THE FIRST 440 RESIDUES OF THE P66.        
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 5810 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 43330 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     PRO A     1                                                      
REMARK 465     ILE A     2                                                      
REMARK 465     SER A     3                                                      
REMARK 465     ILE A    63                                                      
REMARK 465     LYS A    64                                                      
REMARK 465     LYS A    65                                                      
REMARK 465     LYS A    66                                                      
REMARK 465     ASP A    67                                                      
REMARK 465     SER A    68                                                      
REMARK 465     THR A    69                                                      
REMARK 465     LYS A    70                                                      
REMARK 465     TRP A    71                                                      
REMARK 465     ARG A    72                                                      
REMARK 465     GLY A   444                                                      
REMARK 465     ALA A   445                                                      
REMARK 465     ALA A   446                                                      
REMARK 465     ASN A   447                                                      
REMARK 465     ARG A   448                                                      
REMARK 465     GLU A   449                                                      
REMARK 465     THR A   450                                                      
REMARK 465     LYS A   451                                                      
REMARK 465     LEU A   452                                                      
REMARK 465     GLY A   453                                                      
REMARK 465     LYS A   454                                                      
REMARK 465     ALA A   538                                                      
REMARK 465     HIS A   539                                                      
REMARK 465     LYS A   540                                                      
REMARK 465     GLY A   541                                                      
REMARK 465     ILE A   542                                                      
REMARK 465     GLY A   543                                                      
REMARK 465     GLY A   544                                                      
REMARK 465     ASN A   545                                                      
REMARK 465     GLU A   546                                                      
REMARK 465     GLN A   547                                                      
REMARK 465     VAL A   548                                                      
REMARK 465     ASP A   549                                                      
REMARK 465     LYS A   550                                                      
REMARK 465     LEU A   551                                                      
REMARK 465     VAL A   552                                                      
REMARK 465     SER A   553                                                      
REMARK 465     ALA A   554                                                      
REMARK 465     GLY A   555                                                      
REMARK 465     ILE A   556                                                      
REMARK 465     ARG A   557                                                      
REMARK 465     LYS A   558                                                      
REMARK 465     VAL A   559                                                      
REMARK 465     LEU A   560                                                      
REMARK 465     PRO B     1                                                      
REMARK 465     ILE B     2                                                      
REMARK 465     SER B     3                                                      
REMARK 465     PRO B     4                                                      
REMARK 465     ILE B     5                                                      
REMARK 465     GLU B     6                                                      
REMARK 465     TRP B    88                                                      
REMARK 465     GLU B    89                                                      
REMARK 465     VAL B    90                                                      
REMARK 465     GLN B    91                                                      
REMARK 465     LEU B    92                                                      
REMARK 465     GLY B    93                                                      
REMARK 465     ILE B    94                                                      
REMARK 465     LEU B   214                                                      
REMARK 465     TYR B   215                                                      
REMARK 465     THR B   216                                                      
REMARK 465     PRO B   217                                                      
REMARK 465     ASP B   218                                                      
REMARK 465     LYS B   219                                                      
REMARK 465     LYS B   220                                                      
REMARK 465     HIS B   221                                                      
REMARK 465     GLN B   222                                                      
REMARK 465     LYS B   223                                                      
REMARK 465     GLU B   224                                                      
REMARK 465     MET B   357                                                      
REMARK 465     ARG B   358                                                      
REMARK 465     GLY B   359                                                      
REMARK 465     ALA B   360                                                      
REMARK 465     HIS B   361                                                      
REMARK 465     LEU B   429                                                      
REMARK 465     GLU B   430                                                      
REMARK 465     LYS B   431                                                      
REMARK 465     GLU B   432                                                      
REMARK 465     PRO B   433                                                      
REMARK 465     ILE B   434                                                      
REMARK 465     VAL B   435                                                      
REMARK 465     GLY B   436                                                      
REMARK 465     ALA B   437                                                      
REMARK 465     GLU B   438                                                      
REMARK 465     THR B   439                                                      
REMARK 465     PHE B   440                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   NH1  ARG A   277     O3   PO4 A  1301              2.10            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    PRO A 420   C   -  N   -  CA  ANGL. DEV. =  -9.9 DEGREES          
REMARK 500    PRO B 226   C   -  N   -  CA  ANGL. DEV. =  19.5 DEGREES          
REMARK 500    PRO B 226   C   -  N   -  CD  ANGL. DEV. = -22.4 DEGREES          
REMARK 500    PHE B 227   C   -  N   -  CA  ANGL. DEV. = -15.7 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    GLU A   6      170.79    -56.12                                   
REMARK 500    LYS A  20       73.21   -114.97                                   
REMARK 500    LEU A  26     -152.33    -98.35                                   
REMARK 500    PRO A  52       28.35    -57.66                                   
REMARK 500    GLN A  85      159.33    -42.57                                   
REMARK 500    GLU A  89      129.99    -36.37                                   
REMARK 500    VAL A  90       35.05    -68.82                                   
REMARK 500    GLN A  91      108.26     33.16                                   
REMARK 500    PRO A 119     -177.14    -62.49                                   
REMARK 500    THR A 139     -153.28    -96.60                                   
REMARK 500    PRO A 140     -156.26    -60.24                                   
REMARK 500    ILE A 142      127.41    -33.90                                   
REMARK 500    VAL A 148     -153.89   -122.10                                   
REMARK 500    LYS A 154      -71.04    -49.54                                   
REMARK 500    PHE A 160      -70.36    -59.62                                   
REMARK 500    PRO A 170      -76.10    -52.85                                   
REMARK 500    MET A 184     -128.21     58.43                                   
REMARK 500    LEU A 187      105.39   -160.22                                   
REMARK 500    ILE A 195      -44.43    -28.31                                   
REMARK 500    GLN A 222      155.41    -46.46                                   
REMARK 500    MET A 230       53.47     33.97                                   
REMARK 500    PRO A 243      148.25    -31.96                                   
REMARK 500    TRP A 266      -36.69    -32.87                                   
REMARK 500    ILE A 270      -47.57   -138.79                                   
REMARK 500    PRO A 321      -26.87    -37.27                                   
REMARK 500    PRO A 345      125.47    -37.94                                   
REMARK 500    PHE A 346       -3.84     58.37                                   
REMARK 500    TRP A 398      -72.59    -54.54                                   
REMARK 500    TRP A 402      -75.04    -40.33                                   
REMARK 500    THR A 403      -35.29    -29.73                                   
REMARK 500    PRO A 412     -153.01    -55.85                                   
REMARK 500    TYR A 501      -70.08    -54.03                                   
REMARK 500    PRO B  14      125.36    -35.60                                   
REMARK 500    ASP B  67       36.35     36.75                                   
REMARK 500    ILE B 167       -8.46    -57.15                                   
REMARK 500    ASN B 175       48.17   -161.40                                   
REMARK 500    PRO B 176       14.19    -66.50                                   
REMARK 500    MET B 184     -133.83     49.31                                   
REMARK 500    LEU B 193      177.10    -53.18                                   
REMARK 500    ILE B 195      -16.03    -49.60                                   
REMARK 500    PRO B 226      143.21    -12.24                                   
REMARK 500    ASP B 250      -71.58    -52.91                                   
REMARK 500    ALA B 267      -19.73    -48.53                                   
REMARK 500    THR B 286       78.79   -107.66                                   
REMARK 500    GLN B 334       20.13     49.50                                   
REMARK 500    PHE B 346      -23.82     75.16                                   
REMARK 500    LYS B 350      148.21   -175.63                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1300                
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1301                
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NVP A 999                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1VRT   RELATED DB: PDB                                   
REMARK 900 1VRT CONTAINS THE SAME PROTEIN COMPLEXED WITH NEVIRAPINE             
REMARK 900 RELATED ID: 1RTH   RELATED DB: PDB                                   
REMARK 900 1RTH CONTAINS THE SAME PROTEIN COMPLEXED WITH 1051U91                
REMARK 900 RELATED ID: 1VRU   RELATED DB: PDB                                   
REMARK 900 1VRU CONTAINS THE SAME PROTEIN COMPLEXED WITH ALPHA-APA              
REMARK 900 RELATED ID: 1RTI   RELATED DB: PDB                                   
REMARK 900 1RTI CONTAINS THE SAME PROTEIN COMPLEXED WITH HEPT                   
REMARK 900 RELATED ID: 1RTJ   RELATED DB: PDB                                   
REMARK 900 1RTJ CONTAINS THE SAME PROTEIN                                       
REMARK 900 RELATED ID: 1REV   RELATED DB: PDB                                   
REMARK 900 1REV CONTAINS THE SAME PROTEIN COMPLEXED WITH 9-CL-TIBO              
REMARK 900 RELATED ID: 1RT1   RELATED DB: PDB                                   
REMARK 900 1RT1 CONTAINS THE SAME PROTEIN COMPLEXED WITH MKC-442                
REMARK 900 RELATED ID: 1RT2   RELATED DB: PDB                                   
REMARK 900 1RT2 CONTAINS THE SAME PROTEIN COMPLEXED WITH TNK-651                
REMARK 900 RELATED ID: 1KLM   RELATED DB: PDB                                   
REMARK 900 1KLM CONTAINS THE SAME PROTEIN COMPLEXED WITH BHAP (U-90152)         
REMARK 900 RELATED ID: 1RT3   RELATED DB: PDB                                   
REMARK 900 1RT3 CONTAINS AZT DRUG RESISTANT HIV-1 RT MUTANT (RTMC)              
REMARK 900 COMPLEXED WITH 1051U91                                               
REMARK 900 RELATED ID: 1RT4   RELATED DB: PDB                                   
REMARK 900 1RT4 CONTAINS THE SAME PROTEIN COMPLEXED WITH UC-781                 
REMARK 900 RELATED ID: 1RT5   RELATED DB: PDB                                   
REMARK 900 1RT5 CONTAINS THE SAME PROTEIN COMPLEXED WITH UC-10                  
REMARK 900 RELATED ID: 1RT6   RELATED DB: PDB                                   
REMARK 900 1RT6 CONTAINS THE SAME PROTEIN COMPLEXED WITH UC-38                  
REMARK 900 RELATED ID: 1RT7   RELATED DB: PDB                                   
REMARK 900 1RT7 CONTAINS THE SAME PROTEIN COMPLEXED WITH UC-84                  
REMARK 900 RELATED ID: 1C0T   RELATED DB: PDB                                   
REMARK 900 1C0T CONTAINS THE SAME PROTEIN COMPLEXED WITH BM+21.1326             
REMARK 900 RELATED ID: 1C0U   RELATED DB: PDB                                   
REMARK 900 1C0U CONTAINS THE SAME PROTEIN COMPLEXED WITH BM+50.0934             
REMARK 900 RELATED ID: 1C1B   RELATED DB: PDB                                   
REMARK 900 1C1B CONTAINS THE SAME PROTEIN COMPLEXED WITH GCA-186                
REMARK 900 RELATED ID: 1C1C   RELATED DB: PDB                                   
REMARK 900 1C1C CONTAINS THE SAME PROTEIN COMPLEXED WITH TNK-6123               
REMARK 900 RELATED ID: 1DTQ   RELATED DB: PDB                                   
REMARK 900 1DTQ CONTAINS THE SAME PROTEIN COMPLEXED WITH PETT-1                 
REMARK 900 RELATED ID: 1DTT   RELATED DB: PDB                                   
REMARK 900 1DTT CONTAINS THE SAME PROTEIN COMPLEXED WITH PETT-2                 
REMARK 900 RELATED ID: 1EP4   RELATED DB: PDB                                   
REMARK 900 1EP4 CONTAINS THE SAME PROTEIN COMPLEXED WITH S-1153                 
REMARK 900 RELATED ID: 1FK9   RELATED DB: PDB                                   
REMARK 900 1FK9 CONTAINS THE SAME PROTEIN COMPLEXED WITH DMP-226                
REMARK 900 (EFAVIRENZ)                                                          
REMARK 900 RELATED ID: 1FKO   RELATED DB: PDB                                   
REMARK 900 1FKO CONTAINS K103N MUTANT HIV-1 RT COMPLEXED WITH DMP-226           
REMARK 900 (EFAVIRENZ)                                                          
REMARK 900 RELATED ID: 1FKP   RELATED DB: PDB                                   
REMARK 900 1FKP CONTAINS K103N MUTANT HIV-1 RT COMPLEXED WITH                   
REMARK 900 NEVIRAPINE                                                           
REMARK 900 RELATED ID: 1JLA   RELATED DB: PDB                                   
REMARK 900 1JLA CONTAINS Y181C MUTANT HIV-1 RT COMPLEXED TNK-651                
REMARK 900 RELATED ID: 1JLB   RELATED DB: PDB                                   
REMARK 900 1JLB CONTAINS Y181C MUTANT HIV-1 RT COMPLEXED WITH                   
REMARK 900 NEVIRAPINE                                                           
REMARK 900 RELATED ID: 1JLC   RELATED DB: PDB                                   
REMARK 900 1JLC CONTAINS Y181C MUTANT HIV-1 RT COMPLEXED WITH PETT-2            
REMARK 900 RELATED ID: 1JLE   RELATED DB: PDB                                   
REMARK 900 1JLE CONTAINS Y188C MUTANT HIV-1 RT                                  
REMARK 900 RELATED ID: 1JLF   RELATED DB: PDB                                   
REMARK 900 1JLF CONTAINS Y188C MUTANT HIV-1 RT COMPLEXED WITH                   
REMARK 900 NEVIRAPINE                                                           
REMARK 900 RELATED ID: 1JLG   RELATED DB: PDB                                   
REMARK 900 1JLG CONTAINS Y188C MUTANT HIV-1 RT COMPLEXED WITH UC-781            
REMARK 900 RELATED ID: 1JKH   RELATED DB: PDB                                   
REMARK 900 1JKH CONTAINS Y181C MUTANT HIV-1 RT COMPLEXED WITH DMP-226           
REMARK 900 (EFAVIRENZ)                                                          
REMARK 900 RELATED ID: 1JLQ   RELATED DB: PDB                                   
REMARK 900 1JLQ CONTAINS THE SAME PROTEIN COMPLEXED WITH 739W94                 
REMARK 900 RELATED ID: 1LW0   RELATED DB: PDB                                   
REMARK 900 1LW0 CONTAINS T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN            
REMARK 900 COMPLEX WITH NEVIRAPINE                                              
REMARK 900 RELATED ID: 1LWC   RELATED DB: PDB                                   
REMARK 900 1LWC CONTAINS M184V MUTANT HIV-1 REVERSE TRANSCRIPTAS IN             
REMARK 900 COMPLEX WITH NEVIRAPINE                                              
REMARK 900 RELATED ID: 1LWE   RELATED DB: PDB                                   
REMARK 900 1LWE CONTAINS M41L/T215Y MUTANT HIV-1 REVERSE TRANSCR                
REMARK 900 (RTMN) IN COMPLEX WITH NEVIRAPINE                                    
REMARK 900 RELATED ID: 1LWF   RELATED DB: PDB                                   
REMARK 900 1LWF CONTAINS MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+              
REMARK 900 M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH                   
REMARK 900 NEVIRAPINE                                                           
DBREF  1LW0 A    1   560  UNP    P04585   POL_HV1H2      156    715             
DBREF  1LW0 B    1   440  UNP    P04585   POL_HV1H2      156    595             
SEQADV 1LW0 TYR A  215  UNP  P04585    THR   370 ENGINEERED                     
SEQADV 1LW0 CSD A  280  UNP  P04585    CYS   435 MODIFIED RESIDUE               
SEQADV 1LW0 TYR B  215  UNP  P04585    THR   370 ENGINEERED                     
SEQRES   1 A  560  PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS          
SEQRES   2 A  560  PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU          
SEQRES   3 A  560  THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR          
SEQRES   4 A  560  GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO          
SEQRES   5 A  560  GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS          
SEQRES   6 A  560  LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG          
SEQRES   7 A  560  GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN          
SEQRES   8 A  560  LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS          
SEQRES   9 A  560  SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER          
SEQRES  10 A  560  VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE          
SEQRES  11 A  560  THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG          
SEQRES  12 A  560  TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER          
SEQRES  13 A  560  PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU          
SEQRES  14 A  560  PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN          
SEQRES  15 A  560  TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE          
SEQRES  16 A  560  GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS          
SEQRES  17 A  560  LEU LEU ARG TRP GLY LEU TYR THR PRO ASP LYS LYS HIS          
SEQRES  18 A  560  GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU          
SEQRES  19 A  560  HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO          
SEQRES  20 A  560  GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU          
SEQRES  21 A  560  VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY          
SEQRES  22 A  560  ILE LYS VAL ARG GLN LEU CSD LYS LEU LEU ARG GLY THR          
SEQRES  23 A  560  LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA          
SEQRES  24 A  560  GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU          
SEQRES  25 A  560  PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU          
SEQRES  26 A  560  ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR          
SEQRES  27 A  560  TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR          
SEQRES  28 A  560  GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP          
SEQRES  29 A  560  VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR          
SEQRES  30 A  560  GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS          
SEQRES  31 A  560  LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR          
SEQRES  32 A  560  GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE          
SEQRES  33 A  560  VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU          
SEQRES  34 A  560  GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL          
SEQRES  35 A  560  ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA          
SEQRES  36 A  560  GLY TYR VAL THR ASN ARG GLY ARG GLN LYS VAL VAL THR          
SEQRES  37 A  560  LEU THR ASP THR THR ASN GLN LYS THR GLU LEU GLN ALA          
SEQRES  38 A  560  ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN          
SEQRES  39 A  560  ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN          
SEQRES  40 A  560  ALA GLN PRO ASP GLN SER GLU SER GLU LEU VAL ASN GLN          
SEQRES  41 A  560  ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU          
SEQRES  42 A  560  ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU          
SEQRES  43 A  560  GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS VAL          
SEQRES  44 A  560  LEU                                                          
SEQRES   1 B  440  PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS          
SEQRES   2 B  440  PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU          
SEQRES   3 B  440  THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR          
SEQRES   4 B  440  GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO          
SEQRES   5 B  440  GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS          
SEQRES   6 B  440  LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG          
SEQRES   7 B  440  GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN          
SEQRES   8 B  440  LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS          
SEQRES   9 B  440  SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER          
SEQRES  10 B  440  VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE          
SEQRES  11 B  440  THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG          
SEQRES  12 B  440  TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER          
SEQRES  13 B  440  PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU          
SEQRES  14 B  440  PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN          
SEQRES  15 B  440  TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE          
SEQRES  16 B  440  GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS          
SEQRES  17 B  440  LEU LEU ARG TRP GLY LEU TYR THR PRO ASP LYS LYS HIS          
SEQRES  18 B  440  GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU          
SEQRES  19 B  440  HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO          
SEQRES  20 B  440  GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU          
SEQRES  21 B  440  VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY          
SEQRES  22 B  440  ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR          
SEQRES  23 B  440  LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA          
SEQRES  24 B  440  GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU          
SEQRES  25 B  440  PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU          
SEQRES  26 B  440  ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR          
SEQRES  27 B  440  TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR          
SEQRES  28 B  440  GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP          
SEQRES  29 B  440  VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR          
SEQRES  30 B  440  GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS          
SEQRES  31 B  440  LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR          
SEQRES  32 B  440  GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE          
SEQRES  33 B  440  VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU          
SEQRES  34 B  440  GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE                  
MODRES 1LW0 CSD A  280  CYS  3-SULFINOALANINE                                   
HET    CSD  A 280       8                                                       
HET    PO4  A1300       5                                                       
HET    PO4  A1301       5                                                       
HET    NVP  A 999      20                                                       
HETNAM     CSD 3-SULFINOALANINE                                                 
HETNAM     PO4 PHOSPHATE ION                                                    
HETNAM     NVP 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-            
HETNAM   2 NVP  B:2',3'-E][1,4]DIAZEPIN-6-ONE                                   
HETSYN     CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE                       
HETSYN     NVP NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE                           
FORMUL   1  CSD    C3 H7 N O4 S                                                 
FORMUL   3  PO4    2(O4 P 3-)                                                   
FORMUL   5  NVP    C15 H14 N4 O                                                 
HELIX    1   1 THR A   27  GLU A   44  1                                  18    
HELIX    2   2 PHE A   77  THR A   84  1                                   8    
HELIX    3   3 HIS A   96  LEU A  100  5                                   5    
HELIX    4   4 ALA A  114  VAL A  118  5                                   5    
HELIX    5   5 PHE A  124  ALA A  129  5                                   6    
HELIX    6   6 GLY A  155  ASN A  175  1                                  21    
HELIX    7   7 GLU A  194  ARG A  211  1                                  18    
HELIX    8   8 VAL A  254  GLN A  269  1                                  16    
HELIX    9   9 VAL A  276  LEU A  282  1                                   7    
HELIX   10  10 THR A  296  GLU A  312  1                                  17    
HELIX   11  11 ASN A  363  TRP A  383  1                                  21    
HELIX   12  12 GLN A  394  TYR A  405  1                                  12    
HELIX   13  13 THR A  473  SER A  489  1                                  17    
HELIX   14  14 SER A  499  ALA A  508  1                                  10    
HELIX   15  15 SER A  515  LYS A  528  1                                  14    
HELIX   16  16 THR B   27  GLU B   44  1                                  18    
HELIX   17  17 PHE B   77  THR B   84  1                                   8    
HELIX   18  18 GLY B   99  LYS B  103  5                                   5    
HELIX   19  19 GLY B  112  VAL B  118  5                                   7    
HELIX   20  20 PHE B  124  ALA B  129  5                                   6    
HELIX   21  21 SER B  134  GLU B  138  5                                   5    
HELIX   22  22 LYS B  154  ASN B  175  1                                  22    
HELIX   23  23 GLU B  194  TRP B  212  1                                  19    
HELIX   24  24 LEU B  228  GLY B  231  5                                   4    
HELIX   25  25 HIS B  235  TRP B  239  5                                   5    
HELIX   26  26 THR B  253  GLN B  269  1                                  17    
HELIX   27  27 VAL B  276  LEU B  282  1                                   7    
HELIX   28  28 THR B  296  LEU B  310  1                                  15    
HELIX   29  29 ASN B  363  GLY B  384  1                                  22    
HELIX   30  30 GLN B  394  TRP B  406  1                                  13    
HELIX   31  31 PRO B  420  TRP B  426  1                                   7    
SHEET    1   A 3 ILE A  47  LYS A  49  0                                        
SHEET    2   A 3 ARG A 143  TYR A 146 -1  O  GLN A 145   N  SER A  48           
SHEET    3   A 3 PHE A 130  THR A 131 -1  N  PHE A 130   O  TYR A 144           
SHEET    1   B 2 VAL A  60  PHE A  61  0                                        
SHEET    2   B 2 LEU A  74  VAL A  75 -1  O  LEU A  74   N  PHE A  61           
SHEET    1   C 3 SER A 105  VAL A 108  0                                        
SHEET    2   C 3 ASP A 186  SER A 191 -1  O  VAL A 189   N  THR A 107           
SHEET    3   C 3 VAL A 179  TYR A 183 -1  N  TYR A 181   O  TYR A 188           
SHEET    1   D 4 PHE A 227  TRP A 229  0                                        
SHEET    2   D 4 TYR A 232  LEU A 234 -1  O  LEU A 234   N  PHE A 227           
SHEET    3   D 4 LYS A 238  THR A 240 -1  O  THR A 240   N  GLU A 233           
SHEET    4   D 4 GLY A 316  VAL A 317 -1  O  GLY A 316   N  TRP A 239           
SHEET    1   E 2 TRP A 252  THR A 253  0                                        
SHEET    2   E 2 VAL A 292  ILE A 293 -1  O  ILE A 293   N  TRP A 252           
SHEET    1   F 5 LYS A 347  TYR A 354  0                                        
SHEET    2   F 5 GLN A 336  GLU A 344 -1  N  ILE A 341   O  LYS A 350           
SHEET    3   F 5 ILE A 326  GLY A 333 -1  N  ILE A 326   O  TYR A 342           
SHEET    4   F 5 LYS A 388  LEU A 391  1  O  LYS A 388   N  ALA A 327           
SHEET    5   F 5 TRP A 414  PHE A 416  1  O  GLU A 415   N  PHE A 389           
SHEET    1   G 2 HIS A 361  THR A 362  0                                        
SHEET    2   G 2 GLN A 512  SER A 513 -1  N  GLN A 512   O  THR A 362           
SHEET    1   H 5 GLN A 464  VAL A 466  0                                        
SHEET    2   H 5 GLY A 456  THR A 459 -1  N  TYR A 457   O  LYS A 465           
SHEET    3   H 5 THR A 439  VAL A 442 -1  N  TYR A 441   O  VAL A 458           
SHEET    4   H 5 GLU A 492  THR A 497  1  O  VAL A 496   N  PHE A 440           
SHEET    5   H 5 LYS A 530  TRP A 535  1  O  TYR A 532   N  ILE A 495           
SHEET    1   I 3 ILE B  47  LYS B  49  0                                        
SHEET    2   I 3 ILE B 142  TYR B 146 -1  O  GLN B 145   N  SER B  48           
SHEET    3   I 3 PHE B 130  ILE B 132 -1  N  ILE B 132   O  ILE B 142           
SHEET    1   J 2 VAL B  60  LYS B  64  0                                        
SHEET    2   J 2 TRP B  71  VAL B  75 -1  O  LEU B  74   N  PHE B  61           
SHEET    1   K 4 VAL B 179  TYR B 183  0                                        
SHEET    2   K 4 ASP B 186  SER B 191 -1  O  TYR B 188   N  TYR B 181           
SHEET    3   K 4 SER B 105  ASP B 110 -1  N  THR B 107   O  VAL B 189           
SHEET    4   K 4 GLU B 233  LEU B 234 -1  O  LEU B 234   N  VAL B 106           
SHEET    1   L 5 LYS B 347  ALA B 355  0                                        
SHEET    2   L 5 GLN B 336  GLU B 344 -1  N  TRP B 337   O  TYR B 354           
SHEET    3   L 5 ILE B 326  GLY B 333 -1  N  ILE B 326   O  TYR B 342           
SHEET    4   L 5 LYS B 388  LEU B 391  1  O  LYS B 390   N  ALA B 327           
SHEET    5   L 5 GLU B 413  PHE B 416  1  O  GLU B 415   N  LEU B 391           
LINK         C   LEU A 279                 N   CSD A 280     1555   1555  1.32  
LINK         C   CSD A 280                 N   LYS A 281     1555   1555  1.33  
CISPEP   1 PRO A  225    PRO A  226          0         0.16                     
CISPEP   2 PRO A  420    PRO A  421          0         0.10                     
SITE     1 AC1  5 MET A  41  LYS A  73  PHE A 116  TYR A 146                    
SITE     2 AC1  5 GLN A 151                                                     
SITE     1 AC2  6 GLN A 197  LYS A 201  LYS A 275  ARG A 277                    
SITE     2 AC2  6 GLU A 302  GLN A 332                                          
SITE     1 AC3  9 LYS A 101  VAL A 106  VAL A 179  TYR A 181                    
SITE     2 AC3  9 TYR A 188  GLY A 190  PHE A 227  HIS A 235                    
SITE     3 AC3  9 TYR A 318                                                     
CRYST1  139.700  115.000   65.600  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.007158  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.008696  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.015244        0.00000